Bone Therapeutics : 12/15/17 - Bone Therapeutics Provides Update on Equity Placement

The information to which this gatepost gives access does not constitute or form part of an offer or solicitation to purchase or subscribe for new shares in the capital of Bone Therapeutics SA in the United States of America, Australia, Canada, Japan or any jurisdiction in which such an offer or solicitation is unlawful. In particular, the new shares referred to in this information have not been, and will not be, registered under the U.S. Securities Act of 1933 (the 'Securities Act') or under the securities legislation of any state of the United States of America, and may not be offered, sold, resold or delivered, directly or indirectly, in or into the United States of America absent registration except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act. No public offering of securities of Bone Therapeutics will be made in connection with the initial public offering in the United States of America, Australia, Canada, Japan or any jurisdiction in which such public offering is unlawful.

The Company has not authorized any public offering in any Member State of the European Economic Area other than Belgium and France. With respect to each Member State of the European Economic Area other than Belgium and France and which has implemented Directive 2003/71/EC (the 'Prospectus Directive') (each, a 'Relevant Member State'), no action has been undertaken or will be undertaken to make an offer to the public of securities requiring a publication of a prospectus in any Relevant Member State. As a result, the securities referred to in the information may only be offered in a Relevant Member State to qualified investors in that Relevant Member State within the meaning of the Prospectus Directive. For the purposes of this paragraph, the expression an 'offer to the public of securities' in any Relevant Member State means the communication in any form and by any means of sufficient information on the terms of the offer and the securities to be offered so as to enable an investor to decide to purchase any securities, as the same may be varied in that Member State by any measure implementing the Prospectus Directive in that Member State and the expression 'Prospectus Directive' means Directive 2003/71/EC (as amended) and includes any relevant implementing measure in each Relevant Member State.

The information to which this gatepost gives access is only directed at (i) persons who are outside the United Kingdom or (ii) to investment professionals falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the 'Order') or (iii) high net worth companies, and other persons to whom it may lawfully be communicated, falling within Article 49(2)(a) to (d) of the Order (all such persons in (i), (ii) and (iii) above together being referred to as 'relevant persons'). Any invitation, offer or agreement to subscribe, purchase or otherwise acquire securities will be engaged in only with, relevant persons. Any person who is not a relevant person should not act or rely on the information contained herein.

By proceeding to view the information to which this gatepost gives access, you warrant that (i) you are a resident of, and domiciled in, Belgium or France or (y) a 'qualified investor' (within the meaning of the 'Prospectus Directive').

By proceeding to view the information to which this gatepost gives access, you warrant that you have taken note of all the abovementioned information and instructions and you irrevocably and unconditionally undertake to comply with such information and instructions.